[
  {
    "ts": null,
    "headline": "Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization",
    "summary": "RAHWAY, N.J., January 28, 2025--Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization",
    "url": "https://finnhub.io/api/news?id=d130a4f540b6dcffb1475ada43f3f3c1c2041bde187cefcce611c4cb97ef4530",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738088880,
      "headline": "Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization",
      "id": 132505710,
      "image": "https://media.zenfs.com/en/business-wire.com/51e6723dd99a287c3ce86889a237fc1f",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., January 28, 2025--Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization",
      "url": "https://finnhub.io/api/news?id=d130a4f540b6dcffb1475ada43f3f3c1c2041bde187cefcce611c4cb97ef4530"
    }
  },
  {
    "ts": null,
    "headline": "Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?",
    "summary": "We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and entrepreneur, Kevin O’Leary, also known as ‘Mr. Wonderful’ is recognized […]",
    "url": "https://finnhub.io/api/news?id=f1c76682352f2a0891ac048169543afc83604e697cd453283d487f9183ce961e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738088531,
      "headline": "Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025?",
      "id": 132505711,
      "image": "https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and entrepreneur, Kevin O’Leary, also known as ‘Mr. Wonderful’ is recognized […]",
      "url": "https://finnhub.io/api/news?id=f1c76682352f2a0891ac048169543afc83604e697cd453283d487f9183ce961e"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Earnings Expected to Grow: Should You Buy?",
    "summary": "Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=b80510a28d8d2b506309259c57fd93739d1b882ea9dea1b2ccc2eeda98f75cf3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738076448,
      "headline": "Merck (MRK) Earnings Expected to Grow: Should You Buy?",
      "id": 132505712,
      "image": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=b80510a28d8d2b506309259c57fd93739d1b882ea9dea1b2ccc2eeda98f75cf3"
    }
  },
  {
    "ts": null,
    "headline": "Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?",
    "summary": "When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.",
    "url": "https://finnhub.io/api/news?id=ce5389eef0bfd2cba01099ad944fa12d0433dd876a0df374d25050fe3f5aa66d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738074240,
      "headline": "Merck Q4 Earnings Coming Up: Buy, Hold or Sell MRK Stock Now?",
      "id": 132505713,
      "image": "https://media.zenfs.com/en/zacks.com/1b28b8f55ab25205feceb1a2771a2b3a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, Keytruda.",
      "url": "https://finnhub.io/api/news?id=ce5389eef0bfd2cba01099ad944fa12d0433dd876a0df374d25050fe3f5aa66d"
    }
  },
  {
    "ts": null,
    "headline": "Merck Announces $10 Billion Share Repurchase Authorization",
    "summary": "By Stephen Nakrosis Merck said its board authorized an additional $10 billion share repurchase authorization, which has no time limit for completion. The maker of medicines and vaccines has a...",
    "url": "https://finnhub.io/api/news?id=765dc53faf6c2edac17ba1999f4e1d40d05725f3a96a28e74c9ca88064b9e053",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738072872,
      "headline": "Merck Announces $10 Billion Share Repurchase Authorization",
      "id": 132487479,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Stephen Nakrosis Merck said its board authorized an additional $10 billion share repurchase authorization, which has no time limit for completion. The maker of medicines and vaccines has a...",
      "url": "https://finnhub.io/api/news?id=765dc53faf6c2edac17ba1999f4e1d40d05725f3a96a28e74c9ca88064b9e053"
    }
  },
  {
    "ts": null,
    "headline": "Merck Announces Second-Quarter 2025 Dividend, Payable on April 7, 2025",
    "summary": "Merck known as MSD outside of the United States and Canada, announced that the Board of Directors has declared a quarterly dividend of $0.81 per share of the company?s common stock for the second...",
    "url": "https://finnhub.io/api/news?id=4ec52fcbc37d634ddeff1d1073a0620bfebfb49cfadc69e51febccf21eae80ab",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738070880,
      "headline": "Merck Announces Second-Quarter 2025 Dividend, Payable on April 7, 2025",
      "id": 132487555,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck known as MSD outside of the United States and Canada, announced that the Board of Directors has declared a quarterly dividend of $0.81 per share of the company?s common stock for the second...",
      "url": "https://finnhub.io/api/news?id=4ec52fcbc37d634ddeff1d1073a0620bfebfb49cfadc69e51febccf21eae80ab"
    }
  },
  {
    "ts": null,
    "headline": "Merck : Issues Statement on GARDASIL® Litigation - Merck.com",
    "summary": "January 28, 2025 8:55 am ET RAHWAY, N.J., Jan. 28, 2025 - Merck , known as MSD outside of the United States and Canada, today reaffirmed its commitment to defending the safety and...",
    "url": "https://finnhub.io/api/news?id=65840eb9d594e686f6d72fdf4371fad8ecaa3bd4ed96017d1a80fddbc5793198",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738054750,
      "headline": "Merck : Issues Statement on GARDASIL® Litigation - Merck.com",
      "id": 132485863,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "January 28, 2025 8:55 am ET RAHWAY, N.J., Jan. 28, 2025 - Merck , known as MSD outside of the United States and Canada, today reaffirmed its commitment to defending the safety and...",
      "url": "https://finnhub.io/api/news?id=65840eb9d594e686f6d72fdf4371fad8ecaa3bd4ed96017d1a80fddbc5793198"
    }
  }
]